Company contributions to strengthening healthcare capabilities and infrastructure — including in developing and emerging markets — to facilitate access to healthcare and improved quality of healthcare and outcomes.
Investments aligned with our business capabilities
We have three main therapy areas — oncology; cardiovascular, renal and metabolism; and respiratory. Our investments in health systems are aligned to these therapy areas, to ensure connection to our overall company strategy and business model. The stories below outline 2020 progress for each therapy area.
Cardiovascular, renal and metabolism: